Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers-Reference-Cited by-同舟云学术

Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers

Published:2017-11-08 Issue:12 Volume:25 Page:1345-1353
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

Golmard Lisa,Castéra Laurent,Krieger Sophie,Moncoutier Virginie,Abidallah Khadija,Tenreiro Henrique,Laugé Anthony,Tarabeux Julien,Millot Gael A.,Nicolas André,Laé Marick,Abadie Caroline,Berthet Pascaline,Polycarpe Florence,Frébourg Thierry,Elan Camille,de Pauw Antoine,Gauthier-Villars Marion,Buecher Bruno,Stern Marc-Henri^ORCID,Stoppa-Lyonnet Dominique,Vaur Dominique,Houdayer Claude

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://www.nature.com/articles/s41431-017-0021-2.pdf

Reference49 articles.

1. Mavaddat N, Peock S, Frost D, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst. 2013;105:812–22.

2. Antoniou AC, Casadei S, Heikkinen T, et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371:497–506.

3. Norquist BM, Harrell MI, Brady MF, et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016;2:482–90.

4. Easton DF, Lesueur F, Decker B, et al. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. J Med Genet. 2016;53:298–309.

5. Bogliolo M, Surrallés J. Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics. Curr Opin Genet Dev. 2015;33:32–40.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline RAD51C and RAD51D Mutations in High-Risk Chinese Breast and/or Ovarian Cancer Patients and Families;Journal of Personalized Medicine;2024-08-16

2. Primary fallopian tube cancer followed by primary breast cancer in RAD51C mutation carrier treated with niraparib as first line maintenance therapy: a case report;Hereditary Cancer in Clinical Practice;2024-02-15

3. HBV promotes its replication by up-regulating RAD51C gene expression;Scientific Reports;2024-01-31

4. Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?;International Journal of Molecular Sciences;2023-11-30

5. Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus;Breast Cancer Research and Treatment;2023-10-18